肝纤维化诊断新进展  

New Progression of Diagnosis of Liver Fibrosis

作　　者：葛永祥[1] 王丽辉 马健[3] 

机构地区：[1]天津市塘沽区传染病医院传染科,天津300454 [2]北京市中西医结合医院心内科,北京100039 [3]黑龙江中医药大学第一附属医院消化二消化科,哈尔滨150040

出　　处：《医学综述》2011年第19期2952-2955,共4页Medical Recapitulate

摘　　要：肝组织活检仍然是目前诊断肝纤维化的"金标准",但存在着一定的危险性及标本取样的误差性,患者的不合作,使临床应用受到一定的限制。最近,很多学者在多个领域进行了非侵入性方法诊断肝纤维化的研究,并取得了一定的成果。其中包括血清标志物的研究、彩超造影的研究、瞬时弹性图的诊断研究,及CT和磁共振领域的诊断研究。通过多领域的肝纤维化诊断的研究,也为临床医师综合评价肝纤维化提供了丰富的方法和新的思路。Liver biopsy is currently considered the ＂gold standard＂for assessing liver fibrosis.However,limitations of liver biopsy include sampling error,understaging,and its risks.In recent years,clinical diagnosis of the stage of liver fibrosis has evolved in the area of non-invasive assessment of liver fibrosis using serum markers and ultrasound-based and computerized tomography and magnetic resonance imaging technology instead of the ＂gold standard＂ liver biopsy.In addition,these studies have indicated that these non-invasive measures of liver fibrosis could be useful.These results have been become some new thoughts and approaches for clinician to evaluate liver fibrosis progression.

关 键 词：肝纤维化 诊断 新进展 

分 类 号：R575.2[医药卫生—消化系统]